News Related to Paroxysmal Nocturnal Hemoglobinuria

Related coverage linked through entity extraction aliases.

China Medical System Partners with Insilico on AI Drug Discovery, Gains Trial Approval

Feb 13, 2026

China Medical System Holdings partnered with Insilico Medicine on AI-powered drug discovery in early February 2026 and received Chinese regulatory approval to begin human trials for complement factor B inhibitor CMS-D017.

Novartis Vanrafia Phase III Data Show Slowing of Kidney Function Decline in IgA Nephropathy

Feb 13, 2026

Novartis announced final Phase III ALIGN results showing Vanrafia slowed kidney function decline in adults with IgA nephropathy, supporting planned submissions for traditional approval in 2026 following accelerated approvals in the U.S. and China in 2025.